Research is being conducted on next-generation mRNA vaccines that are showing robust protection against multidrug-resistant Enterobacteriaceae. Other approaches, such as peptide vaccines and virus-like particles, are also being explored as potential therapeutic options against antibiotic-resistant bacterial infections. The studies are examining various aspects of immune response, including mucosal immunity, in the context of disease prevention and treatment.